Loyola University Chicago Cardinal Benardin Cancer Center

Maywood, Illinois 60153

0 studies enrolling now · 1 studies all time

What they study most

Myelodysplastic Syndrome

Studies at this site

• Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Completed